1.Executive Summary
A Better Tape, but No Industrial Turn
Research window
2026-02-01 to 2026-02-28
Data vintage
Retrospective edition, researched through 2026-08-05
Linked sources
31 primary and attributable references
Mood 3.1 / 10 · Bearish — fragile stabilization
+0.3 vs. JanuaryFebruary produced the first plausible stabilization story of 2026. Energy prices reaching industrial producers were still falling. Chemical equities mostly rose. BASF expanded butanediol production at Ludwigshafen, and Henkel announced a large specialty-coatings acquisition. Yet none of those facts repaired the sector's central mechanism: German plants still combined weak utilization with structurally high fixed costs, while administrative work and investment continued to migrate toward lower-cost locations.
The last day of the month then changed the risk regime. The escalation in Iran did not yet affect February's official price statistics, but it ended the benign input-cost narrative on which the tentative recovery rested.
Monitoring note. Events are assigned to the calendar month in which they occurred. Later statistical releases are used only to measure that month and are labeled as retrospective. The Mood Index is an editorial composite: demand and output 40%, energy and inputs 20%, company decisions 20%, regulation 10%, and capital-market narrative 10%. It is not a forecast.
Source scope includes VCI, Destatis, and the Federal Ministry for Economic Affairs and Energy (BMWE, formerly BMWK). No ministry production series superseded the VCI/Destatis sector data in this window.
Mood Index: 3.1 / 10 — Bearish, with fragile stabilization
Change from January: +0.3
The improvement was real but narrow. The ifo chemical business climate later placed February at -16.7, better than January's -23.5, while current conditions rose to -21.2. Expectations, however, remained negative at -12.1. Almost 45% of chemical companies reported a deterioration in international competitiveness. A cyclical turn requires demand, utilization, and investment to move together. February delivered only sentiment and share prices.
| Indicator | February reading | Interpretation |
|---|---|---|
| ifo chemical business climate | -16.7 | Better than January, still contractionary |
| Industrial producer energy prices | -1.8% m/m; -12.5% y/y | Backward-looking relief before the war shock |
| International competitiveness | 45% reporting deterioration | Structural weakness remained dominant |
| Sector employment baseline | 478,000 at end-2025; -0.5% y/y | No evidence of a hiring turn |
| Industrial electricity subsidy | Not yet approved | Political promise, not February cash relief |
Top three events
- Henkel agreed to acquire Stahl for €2.1 billion. The deal moved Henkel deeper into high-value specialty coatings rather than German commodity capacity.
- BASF paired a Ludwigshafen production increase with service migration to Asia. This was the month's clearest image of the emerging Standort D model: selective process investment at home, scalable overhead elsewhere.
- The Iran conflict escalated on February 28. The event arrived too late for the month's price data but invalidated the calm-energy baseline.
Strategic conclusion
The February rally should be read as a repricing of extreme pessimism, not as proof of recovery. The falsification test is simple: a durable turn would require chemical orders, capacity utilization, and domestic capital expenditure to improve after the energy shock. At month-end, none had done so.
2.Macroeconomic & Regulatory Landscape
Demand, energy, policy, and the Standort D cost stack
Output, sales, and employment
No new VCI quarterly report was published during February. The latest available sector baseline remained the fourth quarter of 2025: chemical output had fallen 2.4% quarter on quarter and 2.9% year on year; chemical and pharmaceutical sales were €51.8 billion, down 2.8% year on year; and chemical capacity utilization stood at only 72.5%. Employment across chemicals and pharmaceuticals had fallen 0.5% to just under 478,000, with chemical employment down a little more than 1%.
Destatis added one useful leading clue. In December 2025, production in energy-intensive industry was 2.6% below the prior-year level. The sector was therefore entering February from a depressed base, not from an expanding one.
The official statements converged. The VCI described the recovery signals in customer industries as insufficient to reach chemical order books. The ifo Institute found that 45% of chemical companies saw their international competitiveness worsening. The economic problem was not simply low demand. Low utilization raised unit costs, which weakened pricing, which encouraged customers to import, which further reduced utilization.
Sources: VCI Q4 2025 report, Destatis industrial production, ifo competitiveness survey, ifo February exporter expectations
Energy: relief in the invoice, risk in the market
German producer energy prices fell 1.8% from January and 12.5% year on year in February. Consumer-energy data told the same backward-looking story: household gas and electricity prices were each down more than 4% from a year earlier. The Iran escalation began on the final day, so the February data contain virtually none of the subsequent oil, gas, electricity, and logistics shock.
The policy distinction also matters. Germany had reduced network costs through a €6.5 billion grid subsidy, abolished the gas-storage levy, and lowered electricity tax for producing firms to the EU minimum. Strompreiskompensation continued for eligible indirect carbon costs, but no new February rule changed its plant-level reach. The planned industrial electricity price, however, was not operational in February. It still required notification and European Commission approval. Treating an announced subsidy as a realized plant-level cost reduction would confuse political intent with cash economics.
Sources: Destatis producer prices, February, Destatis consumer prices, February, Federal energy-cost measures
Regulation and subsidies
The European Commission approved a €3 billion German state-aid scheme for clean-technology manufacturing on February 4. For chemical companies, the instrument was relevant less as immediate demand than as a signal about where European industrial policy was moving: production support was becoming conditional, targeted, and technology-specific.
The EU's “one substance, one assessment” package had entered into force at the start of the year and remained the most relevant horizontal chemicals-regulation change. It promised less duplication across agencies, but its value would depend on implementation speed. No material REACH restriction decision changed the operating case during February.
Sources: European Commission — €3 billion German clean-tech scheme, European Commission — one substance, one assessment
3.Corporate Movers & Shakers
Eight-company decision ledger and Standort D implications
| Company | February event | Standort D reading |
|---|---|---|
| BASF | FY2025 results; finance and HR services bundled in India and supply-chain activities in Kuala Lumpur; BDO output increased at Ludwigshafen | Selective German process investment, global overhead migration |
| Bayer | Nationwide Roundup settlement framework announced | Litigation de-risking dominated; no new German capacity decision |
| Covestro | FY2025 results; CEO Markus Steilemann said he would leave after his term in 2028 | Takeover integration, weak cash generation, no fresh closure announcement |
| Evonik | Preliminary FY2025 adjusted EBITDA €1.87bn; 2026 range €1.7–2.0bn; HTPB capacity expansion in Germany and Asia | Dual-location capacity strategy rather than German retreat alone |
| Lanxess | No material M&A, closure, or earnings disclosure in the window | Existing restructuring case unchanged |
| Wacker Chemie | No new material disclosure after January preliminary results | Cost program remained the operative Standort D signal |
| Henkel | Agreed to acquire Stahl for €2.1bn; Stahl had about €725m sales and 1,700 employees | Offensive portfolio shift toward specialty coatings |
| Merck KGaA | No material M&A, closure, or earnings disclosure in the window | Strategy unchanged ahead of March results |
BASF's full-year numbers captured the sector's asymmetry. Sales fell to about €59.7 billion and EBITDA before special items to roughly €6.6 billion. The company had achieved a substantial cost-savings run rate, but its 2026 outlook still assumed no meaningful near-term market recovery. Moving repeatable service processes to India and Malaysia reduces overhead. It also narrows the German employment base around the physical Verbund.
Henkel's Stahl acquisition was the counterexample. The company used balance-sheet capacity to buy know-how, customer access, and formulation economics. It was not a vote for German bulk production, but it showed that European chemical capital had not become uniformly defensive.
Sources: BASF service organization, BASF Ludwigshafen BDO expansion, BASF FY2025 results, Bayer Roundup settlement, Covestro FY2025, Evonik February releases, Henkel–Stahl
4.Innovation & Transformation
From pilots and platforms to bankable industrial scale
February's innovation news was incremental but economically relevant. BASF's BDO increase used existing Ludwigshafen integration rather than a greenfield build. Evonik announced additional hydroxyl-terminated polybutadiene capacity in both Germany and Asia, with the first phase expected in 2027. The architecture was revealing: firms were preserving German process competence while distributing volume and market access.
The wider European circular-economy and hydrogen narrative remained constrained by scale. CHEManager's coverage of the Cefic/Roland Berger closure radar reported 37 million metric tons of European capacity announced for closure since 2022, compared with sharply falling new investment. Hydrogen, CCUS, and circular pilots can improve the technology set. They do not restore competitiveness unless power, carbon, and capital costs permit deployment beyond pilot scale.
Sources: Evonik HTPB capacity, CHEManager — Europe's chemical sector under stress, CHEManager — Antwerp competitiveness call
5.Financial, Narrative & Falsification Radar
Equities, analyst evidence, media language, and what would change the view
One-month equity performance
Method: last available Xetra close in January to last available Xetra close in February, unadjusted for dividends and rounded. Up means above +2%; Down below -2%; values in between are Neutral. This is a price trend, not investment advice.
| Company | February performance | Trend |
|---|---|---|
| BASF | +6.0% | Up |
| Bayer | -5.7% | Down |
| Covestro | Takeover-capped near the squeeze-out value | Neutral |
| Evonik | +12.9% | Up |
| Lanxess | +9.5% | Up |
| Wacker Chemie | +17.7% | Up |
| Henkel | +12.2% | Up |
| Merck KGaA | +2.2% | Up |
The breadth of the rally is the point. Seven of the eight names were not all improving operationally; the market was reducing a recession discount. Bayer was the exception because litigation uncertainty remained too large for the settlement announcement to close the valuation gap.
Analyst-rating tape
No fresh upgrade or downgrade from Deutsche Bank or Goldman Sachs for the eight-name universe could be verified in the February window. That absence is preferable to recycling old calls as new information. Deutsche Bank's public recommendation history next recorded Bayer as Hold on March 5, which was a reiteration rather than a February change.
Price sources: BASF, Bayer, Covestro, Evonik, Lanxess, Wacker, Henkel, Merck KGaA. Rating source: Deutsche Bank recommendation history.
Headline and Mood Index
Media method: Public headlines and indexed snippets from Handelsblatt, FAZ, CHEManager, and Börsen-Zeitung were reviewed for vocabulary and emphasis. Paywalled or crawler-restricted text was not used as the sole support for a factual claim.
The monitored headline vocabulary remained overwhelmingly negative. Handelsblatt's month-end framing was “another crisis year.” CHEManager wrote of a sector “under stress” and an industrial “competitiveness collapse.” Publicly indexed FAZ and Börsen-Zeitung coverage was thinner, but company reporting still emphasized savings, portfolio repair, and litigation rather than recovery.
| Keyword | February signal | Reading |
|---|---|---|
| Deindustrialization | High | Closures, overseas service migration, weak investment |
| Recovery | Low to medium | Equity rally and lower reported energy costs |
| Crisis | High | Low utilization and no management expectation of a turn |
Sources: Handelsblatt — another crisis year, CHEManager — Europe's chemical sector under stress
What Would Change the View?
A rating above 4 would require three observable changes: chemical orders rising without precautionary stock-building, utilization moving decisively above the mid-70s, and domestic investment decisions outnumbering closures or relocations. February supplied none of the three. The tape improved; the industrial equation did not.